Subtitle:

Immunomodulatory effects of selected chemotherapeutics

Publisher:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Abstract:

Chemotherapeutics are still regarded as a mainstay of antitumor strategies.A number of observations indicate that these agents might be used at low doseswith the same or even better efficacy than the high-dose chemotherapy. The efficacy of the low-dose chemotherapy might be at least partly explained by theregulation of the antitumor immune response. These immunomodulatory effects might be further potentiated by combinations with selected biological response modifiers, such as recombinant cytokines (lL-2, TNF, IL-12). The effectiveness of such combinations has already proved encouraging in pre-clinicalmodels.

Relation:

Biotechnologia, vol.54, 3 (2001)-.

Volume:

54

Issue:

3

Start page:

78

End page:

85

Detailed Resource Type:

Article

Format:

application/pdf

Resource Identifier:

0860-7796 ; oai:rcin.org.pl:138860 ; IChB B-50

Source:

Library of Institute of Bioorganic Chemistry PAS

Language:

pol

Language of abstract:

eng

Temporal coverage:

1988-2010

Rights:

Creative Commons Attribution BY-SA 4.0 license

Terms of use:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitizing institution:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Original in:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Projects co-financed by:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Access:

Open